v3.26.1
Stock-Based Compensation (Tables)
 9 Months Ended
Mar. 27, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Options
The following table summarizes activity with respect to Company-issued stock options since June 27, 2025:
Options Outstanding
Number of
Shares		Weighted Average
Grant Date
Fair Value		Weighted Average
Exercise Price		Weighted Average
Remaining
Contractual Term
(Years)		Aggregate
Intrinsic Value as of March 27, 2026
Outstanding at June 27, 2025934 $12.71 $45.00 — 
Granted— — 
Exercised— — 
Canceled— — 
Outstanding at March 27, 2026934 12.71 45.00 2.14 years— 
Exercisable at March 27, 2026— $— $— — — 
Schedule of Restricted Stock Awards
The following table summarizes the status of the Company’s non-vested restricted stock awards and deferred stock awards since June 27, 2025:
 Non-vested Restricted Stock Awards
 Number of
Shares		Weighted Average
Grant Date
Fair Value
Non-vested at June 27, 20251,742 $40.37 
Granted570 69.28 
Vested(481)40.87 
Forfeited(131)48.52 
Non-vested at March 27, 20261,700 $49.36 
Schedule of Stock-Based Compensation Expense
The following table presents share-based compensation expenses included in the Company’s Consolidated Statements of Operations and Comprehensive Income (Loss):
 Third Quarters EndedNine Months Ended
 March 27, 2026March 28, 2025March 27, 2026March 28, 2025
Cost of revenues$950 $813 $4,573 $759 
Selling, general and administrative6,556 6,228 19,878 17,156 
Research and development1,543 1,507 4,765 4,687 
Stock-based compensation expense before tax9,049 8,548 29,216 22,602 
Income taxes(1)
(2,443)(2,308)(7,888)(6,103)
Stock-based compensation expense, net of income taxes$6,606 $6,240 $21,328 $16,499 
(1) Federal and state statutory rate of 27%